ProfileGDS4459 / ENSG00000124900
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 20% 13% 15% 10% 30% 15% 23% 27% 6% 32% 22% 24% 30% 32% 17% 28% 14% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.3420
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.0813
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.6315
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.9910
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.6330
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.9515
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.1723
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.3827
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 91.986
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.732
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.2922
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.1924
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.6130
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.8632
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.7617
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.6828
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.1214